Allspring Global Investments Holdings LLC reduced its position in Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 42.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,663 shares of the semiconductor company’s stock after selling 2,669 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Axcelis Technologies were worth $384,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Signaturefd LLC lifted its stake in Axcelis Technologies by 348.9% during the 2nd quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after acquiring an additional 164 shares in the last quarter. Blue Trust Inc. lifted its stake in Axcelis Technologies by 223.8% during the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after acquiring an additional 188 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new position in Axcelis Technologies during the 2nd quarter valued at $39,000. Isthmus Partners LLC lifted its stake in Axcelis Technologies by 87.3% during the 2nd quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock valued at $47,000 after acquiring an additional 15,507 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new position in Axcelis Technologies during the 2nd quarter valued at $69,000. 89.98% of the stock is currently owned by institutional investors.
Axcelis Technologies Trading Up 0.9 %
Shares of ACLS opened at $86.09 on Friday. The business has a 50-day moving average of $99.27 and a 200 day moving average of $113.66. Axcelis Technologies, Inc. has a fifty-two week low of $85.26 and a fifty-two week high of $158.61. The firm has a market cap of $2.81 billion, a P/E ratio of 11.86, a price-to-earnings-growth ratio of 2.72 and a beta of 1.58. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.26 and a current ratio of 4.42.
Wall Street Analyst Weigh In
ACLS has been the topic of several recent analyst reports. Bank of America raised their price objective on Axcelis Technologies from $125.00 to $150.00 and gave the company a “neutral” rating in a research note on Wednesday, July 10th. Benchmark dropped their price objective on Axcelis Technologies from $180.00 to $175.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Craig Hallum lifted their target price on Axcelis Technologies from $130.00 to $174.00 and gave the stock a “buy” rating in a research note on Friday, July 12th. DA Davidson lifted their target price on Axcelis Technologies from $150.00 to $175.00 and gave the stock a “buy” rating in a research note on Monday, July 15th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Axcelis Technologies in a research note on Friday, August 2nd. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $167.33.
View Our Latest Analysis on Axcelis Technologies
Insider Buying and Selling
In related news, Director Jorge Titinger sold 6,086 shares of Axcelis Technologies stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $109.98, for a total value of $669,338.28. Following the completion of the sale, the director now owns 5,891 shares of the company’s stock, valued at approximately $647,892.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.43% of the stock is currently owned by insiders.
About Axcelis Technologies
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Read More
- Five stocks we like better than Axcelis Technologies
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Battle of the Retailers: Who Comes Out on Top?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.